BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37055887)

  • 1. Anticancer Compounds from Cyanobacteria and their Implications in Apoptosis.
    Gupta A; Singh PR; Singh AP; Kumari N; Jaiswal J; Sahu N; Mishra S; Pathak J; Sinha RP
    Curr Protein Pept Sci; 2023; 24(10):805-819. PubMed ID: 37055887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marine cyanobacteria compounds with anticancer properties: a review on the implication of apoptosis.
    Costa M; Costa-Rodrigues J; Fernandes MH; Barros P; Vasconcelos V; Martins R
    Mar Drugs; 2012 Oct; 10(10):2181-2207. PubMed ID: 23170077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyanobacteria as Natural Therapeutics and Pharmaceutical Potential: Role in Antitumor Activity and as Nanovectors.
    Qamar H; Hussain K; Soni A; Khan A; Hussain T; Chénais B
    Molecules; 2021 Jan; 26(1):. PubMed ID: 33466486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyanobacteria derived compounds: Emerging drugs for cancer management.
    Shahid A; Khurshid M; Aslam B; Muzammil S; Mehwish HM; Rajoka MSR; Hayat HF; Sarfraz MH; Razzaq MK; Nisar MA; Waseem M
    J Basic Microbiol; 2022 Sep; 62(9):1125-1142. PubMed ID: 34747529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pramanicin analog induces apoptosis in human colon cancer cells: critical roles for Bcl-2, Bim, and p38 MAPK signaling.
    Bodur C; Kutuk O; Karsli-Uzunbas G; Isimjan TT; Harrison P; Basaga H
    PLoS One; 2013; 8(2):e56369. PubMed ID: 23441183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells.
    Ballestrero A; Nencioni A; Boy D; Rocco I; Garuti A; Mela GS; Van Parijs L; Brossart P; Wesselborg S; Patrone F
    Clin Cancer Res; 2004 Feb; 10(4):1463-70. PubMed ID: 14977850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BM-1197: a novel and specific Bcl-2/Bcl-xL inhibitor inducing complete and long-lasting tumor regression in vivo.
    Bai L; Chen J; McEachern D; Liu L; Zhou H; Aguilar A; Wang S
    PLoS One; 2014; 9(6):e99404. PubMed ID: 24901320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells.
    Nencioni A; Wille L; Dal Bello G; Boy D; Cirmena G; Wesselborg S; Belka C; Brossart P; Patrone F; Ballestrero A
    Clin Cancer Res; 2005 Jun; 11(11):4259-65. PubMed ID: 15930365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Small Inhibitory Molecules Targeting the Bfl-1 Anti-Apoptotic Protein That Alleviates Resistance to ABT-737.
    Mathieu AL; Sperandio O; Pottiez V; Balzarin S; Herlédan A; Elkaïm JO; Fogeron ML; Piveteau C; Dassonneville S; Deprez B; Villoutreix BO; Bonnefoy N; Leroux F
    J Biomol Screen; 2014 Aug; 19(7):1035-46. PubMed ID: 24809353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer and Apoptosis.
    Chaudhry GE; Akim AM; Sung YY; Muhammad TST
    Methods Mol Biol; 2022; 2543():191-210. PubMed ID: 36087269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An inhibitor of Bcl-2 family proteins induces regression of solid tumours.
    Oltersdorf T; Elmore SW; Shoemaker AR; Armstrong RC; Augeri DJ; Belli BA; Bruncko M; Deckwerth TL; Dinges J; Hajduk PJ; Joseph MK; Kitada S; Korsmeyer SJ; Kunzer AR; Letai A; Li C; Mitten MJ; Nettesheim DG; Ng S; Nimmer PM; O'Connor JM; Oleksijew A; Petros AM; Reed JC; Shen W; Tahir SK; Thompson CB; Tomaselli KJ; Wang B; Wendt MD; Zhang H; Fesik SW; Rosenberg SH
    Nature; 2005 Jun; 435(7042):677-81. PubMed ID: 15902208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABT-737 induces expression of the death receptor 5 and sensitizes human cancer cells to TRAIL-induced apoptosis.
    Song JH; Kandasamy K; Kraft AS
    J Biol Chem; 2008 Sep; 283(36):25003-13. PubMed ID: 18599488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship studies of ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (HA 14-1), an antagonist for antiapoptotic Bcl-2 proteins to overcome drug resistance in cancer.
    Doshi JM; Tian D; Xing C
    J Med Chem; 2006 Dec; 49(26):7731-9. PubMed ID: 17181155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of phosphatidylinositol 3-kinase/AKT signaling by NVP-BKM120 promotes ABT-737-induced toxicity in a caspase-dependent manner through mitochondrial dysfunction and DNA damage response in established and primary cultured glioblastoma cells.
    Jane EP; Premkumar DR; Morales A; Foster KA; Pollack IF
    J Pharmacol Exp Ther; 2014 Jul; 350(1):22-35. PubMed ID: 24741074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy.
    Tomek M; Akiyama T; Dass CR
    J Pharm Pharmacol; 2012 Dec; 64(12):1695-702. PubMed ID: 23146031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of 3-phenyl-N-(2-(3-phenylureido)ethyl)-thiophene-2-sulfonamide compounds as inhibitors of antiapoptotic Bcl-2 family proteins.
    Yang C; Chen S; Zhou M; Li Y; Li Y; Zhang Z; Liu Z; Ba Q; Li J; Wang H; Yan X; Ma D; Wang R
    ChemMedChem; 2014 Jul; 9(7):1436-52. PubMed ID: 24782462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological inhibition of the Bcl-2 family of apoptosis regulators as cancer therapy.
    Richardson A; Kaye SB
    Curr Mol Pharmacol; 2008 Nov; 1(3):244-54. PubMed ID: 20021437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B Cell Lymphoma 2: A Potential Therapeutic Target for Cancer Therapy.
    Alam M; Ali S; Mohammad T; Hasan GM; Yadav DK; Hassan MI
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel peptide isolated from garlic shows anticancer effect against leukemic cell lines via interaction with Bcl-2 family proteins.
    Rasaratnam K; Nantasenamat C; Phaonakrop N; Roytrakul S; Tanyong D
    Chem Biol Drug Des; 2021 May; 97(5):1017-1028. PubMed ID: 33595876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astrakurkurone, a sesquiterpenoid from wild edible mushroom, targets liver cancer cells by modulating Bcl-2 family proteins.
    Dasgupta A; Dey D; Ghosh D; Lai TK; Bhuvanesh N; Dolui S; Velayutham R; Acharya K
    IUBMB Life; 2019 Jul; 71(7):992-1002. PubMed ID: 30977280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.